Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 5:20 pm Sale | 2026-06-30 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Perceptive Advisors LLC | 11,634,211 9.100% | -1,180,902 (-9.21%) | Filing History |
| 2026-06-30 5:13 pm Sale | 2026-06-26 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | AH Bio Fund II L.P. | 9,063,054 7.100% | -3,590,863 (-28.38%) | Filing History |
| 2026-06-04 4:54 pm Sale | 2026-06-02 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | AH Bio Fund II L.P. | 12,653,917 9.900% | -5,000,000 (-28.32%) | Filing History |
| 2026-03-04 7:33 pm Purchase | 2026-03-02 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Sujal Patel | 21,249,965 16.300% | 952,233 (+4.69%) | Filing History |
| 2026-03-04 7:33 pm Purchase | 2026-03-02 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Parag Mallick | 22,557,411 17.600% | 293,500 (+1.32%) | Filing History |
| 2025-06-24 4:42 pm Purchase | 2025-06-20 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Perceptive Advisors LLC | 12,815,113 10.100% | 220,902 (+1.75%) | Filing History |
| 2025-03-05 4:57 pm Purchase | 2025-03-03 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Parag Mallick | 22,263,911 17.400% | 1,110,000 (+5.25%) | Filing History |
| 2025-03-05 4:54 pm Purchase | 2025-03-03 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Sujal Patel | 20,297,732 15.700% | 2,800,000 (+16.00%) | Filing History |
| 2025-01-31 9:06 pm Unchanged | 2025-01-31 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Perceptive Advisors LLC | 12,594,211 10.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:31 pm Unchanged | 2024-11-14 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Perceptive Advisors LLC | 12,594,211 10.000% | 0 (Unchanged) | Filing History |
| 2023-11-16 9:18 pm Purchase | 2023-11-15 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Perceptive Advisors LLC | 12,594,211 10.100% | 3,683,060 (+41.33%) | Filing History |
| 2023-03-01 3:30 pm Purchase | 2023-02-27 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Nautilus Biotechnology, Inc. NAUT | 18,947,732 15.000% | 18,947,732 (New Position) | Filing History |
| 2023-02-13 4:15 pm Purchase | 2022-12-31 | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | Cercano Management LLC | 7,172,985 5.800% | 7,172,985 (New Position) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | RA Capital Management, L.P. | 2,436,430 2.000% | 1,436,430 (+143.64%) | Filing History |
| 2022-02-10 4:19 pm Purchase | 2021-12-31 | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | VCVC V LLC | 7,172,985 5.800% | 7,172,985 (New Position) | Filing History |
| 2021-08-25 8:58 pm Purchase | 2021-06-09 | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | McIlwain Matthew S | 6,368,136 5.130% | 6,368,136 (New Position) | Filing History |